APO RESEARCH · REPORT
Heart Defect Closure Devices
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Product & engineering
Understand the product.
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Selected research
Market Outlook & Growth Opportunities
Global Heart Defect Closure Devices Market Outlook and Growth Opportunities 2026
Market perspective
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Global Heart Defect Closure Devices key players include St. Jude Medical, Starway, LifeTech, etc. Global top three manufacturers hold a share about 85%.
United States is the largest market, with a share about 70%, followed by Europe and China, both have a share over 25 percent.
Read the full market overview
In terms of product, ASD Closure Devices is the largest segment, with a share about 40%.
This report provides an overview of the global Heart Defect Closure Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Heart Defect Closure Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Heart Defect Closure Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heart Defect Closure Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Heart Defect Closure Devices Segment by Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort
Heart Defect Closure Devices Segment by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Heart Defect Closure Devices Segment by Application
Hospitals
Clinics
Heart Defect Closure Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Heart Defect Closure Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Heart Defect Closure Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Heart Defect Closure Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Heart Defect Closure Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Defect Closure Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heart Defect Closure Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Defect Closure Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Heart Defect Closure Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heart Defect Closure Devices industry.
Chapter 3: Detailed analysis of Heart Defect Closure Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Heart Defect Closure Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Heart Defect Closure Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- ASD Closure Devices
- VSD Closure Devices
- PDA Closure Devices
- PFO Closure Devices
- LAA Closure Devices
Applications
- Hospitals
- Clinics
Companies covered
- Abbott
- Boston Scientific
- LifeTech
- Lepu Medical
- Occlutech
- W. L. Gore and Associates
- Starway
- Coherex Medical
- Cardia
- MicroPort
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Heart Defect Closure Devices Sales Value (2021-2032)
- 1.2.2 Global Heart Defect Closure Devices Sales Volume (2021-2032)
- 1.2.3 Global Heart Defect Closure Devices Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Heart Defect Closure Devices Market Dynamics
- 2.1 Heart Defect Closure Devices Industry Trends
- 2.2 Heart Defect Closure Devices Industry Drivers
- 2.3 Heart Defect Closure Devices Industry Opportunities and Challenges
- 2.4 Heart Defect Closure Devices Industry Restraints
3 Heart Defect Closure Devices Market by Company
- 3.1 Global Heart Defect Closure Devices Company Revenue Ranking in 2025
- 3.2 Global Heart Defect Closure Devices Revenue by Company (2021-2026)
- 3.3 Global Heart Defect Closure Devices Sales Volume by Company (2021-2026)
- 3.4 Global Heart Defect Closure Devices Average Price by Company (2021-2026)
- 3.5 Global Heart Defect Closure Devices Company Ranking (2024-2026)
- 3.6 Global Heart Defect Closure Devices Company Manufacturing Base and Headquarters
- 3.7 Global Heart Defect Closure Devices Company Product Type and Application
- 3.8 Global Heart Defect Closure Devices Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Heart Defect Closure Devices Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Heart Defect Closure Devices Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Heart Defect Closure Devices Market by Type
- 4.1 Heart Defect Closure Devices Type Introduction
- 4.1.1 ASD Closure Devices
- 4.1.2 VSD Closure Devices
- 4.1.3 PDA Closure Devices
- 4.1.4 PFO Closure Devices
- 4.1.5 LAA Closure Devices
- 4.2 Global Heart Defect Closure Devices Sales Volume by Type
- 4.2.1 Global Heart Defect Closure Devices Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Heart Defect Closure Devices Sales Volume by Type (2021-2032)
- 4.2.3 Global Heart Defect Closure Devices Sales Volume Share by Type (2021-2032)
- 4.3 Global Heart Defect Closure Devices Sales Value by Type
- 4.3.1 Global Heart Defect Closure Devices Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Heart Defect Closure Devices Sales Value by Type (2021-2032)
- 4.3.3 Global Heart Defect Closure Devices Sales Value Share by Type (2021-2032)
5 Heart Defect Closure Devices Market by Application
- 5.1 Heart Defect Closure Devices Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Heart Defect Closure Devices Sales Volume by Application
- 5.2.1 Global Heart Defect Closure Devices Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Heart Defect Closure Devices Sales Volume by Application (2021-2032)
- 5.2.3 Global Heart Defect Closure Devices Sales Volume Share by Application (2021-2032)
- 5.3 Global Heart Defect Closure Devices Sales Value by Application
- 5.3.1 Global Heart Defect Closure Devices Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Heart Defect Closure Devices Sales Value by Application (2021-2032)
- 5.3.3 Global Heart Defect Closure Devices Sales Value Share by Application (2021-2032)
6 Heart Defect Closure Devices Regional Sales and Value Analysis
- 6.1 Global Heart Defect Closure Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Heart Defect Closure Devices Sales by Region (2021-2032)
- 6.2.1 Global Heart Defect Closure Devices Sales by Region: 2021-2026
- 6.2.2 Global Heart Defect Closure Devices Sales by Region (2027-2032)
- 6.3 Global Heart Defect Closure Devices Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Heart Defect Closure Devices Sales Value by Region (2021-2032)
- 6.4.1 Global Heart Defect Closure Devices Sales Value by Region: 2021-2026
- 6.4.2 Global Heart Defect Closure Devices Sales Value by Region (2027-2032)
- 6.5 Global Heart Defect Closure Devices Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Heart Defect Closure Devices Sales Value (2021-2032)
- 6.6.2 North America Heart Defect Closure Devices Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Heart Defect Closure Devices Sales Value (2021-2032)
- 6.7.2 Europe Heart Defect Closure Devices Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Heart Defect Closure Devices Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Heart Defect Closure Devices Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Heart Defect Closure Devices Sales Value (2021-2032)
- 6.9.2 South America Heart Defect Closure Devices Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Heart Defect Closure Devices Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Heart Defect Closure Devices Sales Value Share by Country, 2025 VS 2032
7 Heart Defect Closure Devices Country-level Sales and Value Analysis
- 7.1 Global Heart Defect Closure Devices Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Heart Defect Closure Devices Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Heart Defect Closure Devices Sales by Country (2021-2032)
- 7.3.1 Global Heart Defect Closure Devices Sales by Country (2021-2026)
- 7.3.2 Global Heart Defect Closure Devices Sales by Country (2027-2032)
- 7.4 Global Heart Defect Closure Devices Sales Value by Country (2021-2032)
- 7.4.1 Global Heart Defect Closure Devices Sales Value by Country (2021-2026)
- 7.4.2 Global Heart Defect Closure Devices Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.9.2 France Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.16.2 China Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.19.2 India Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Heart Defect Closure Devices Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Heart Defect Closure Devices Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Heart Defect Closure Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Abbott Heart Defect Closure Devices Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Boston Scientific
- 8.2.1 Boston Scientific Company Information
- 8.2.2 Boston Scientific Business Overview
- 8.2.3 Boston Scientific Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Boston Scientific Heart Defect Closure Devices Product Portfolio
- 8.2.5 Boston Scientific Recent Developments
- 8.3 LifeTech
- 8.3.1 LifeTech Company Information
- 8.3.2 LifeTech Business Overview
- 8.3.3 LifeTech Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.3.4 LifeTech Heart Defect Closure Devices Product Portfolio
- 8.3.5 LifeTech Recent Developments
- 8.4 Lepu Medical
- 8.4.1 Lepu Medical Company Information
- 8.4.2 Lepu Medical Business Overview
- 8.4.3 Lepu Medical Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Lepu Medical Heart Defect Closure Devices Product Portfolio
- 8.4.5 Lepu Medical Recent Developments
- 8.5 Occlutech
- 8.5.1 Occlutech Company Information
- 8.5.2 Occlutech Business Overview
- 8.5.3 Occlutech Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Occlutech Heart Defect Closure Devices Product Portfolio
- 8.5.5 Occlutech Recent Developments
- 8.6 W. L. Gore and Associates
- 8.6.1 W. L. Gore and Associates Company Information
- 8.6.2 W. L. Gore and Associates Business Overview
- 8.6.3 W. L. Gore and Associates Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.6.4 W. L. Gore and Associates Heart Defect Closure Devices Product Portfolio
- 8.6.5 W. L. Gore and Associates Recent Developments
- 8.7 Starway
- 8.7.1 Starway Company Information
- 8.7.2 Starway Business Overview
- 8.7.3 Starway Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Starway Heart Defect Closure Devices Product Portfolio
- 8.7.5 Starway Recent Developments
- 8.8 Coherex Medical
- 8.8.1 Coherex Medical Company Information
- 8.8.2 Coherex Medical Business Overview
- 8.8.3 Coherex Medical Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Coherex Medical Heart Defect Closure Devices Product Portfolio
- 8.8.5 Coherex Medical Recent Developments
- 8.9 Cardia
- 8.9.1 Cardia Company Information
- 8.9.2 Cardia Business Overview
- 8.9.3 Cardia Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Cardia Heart Defect Closure Devices Product Portfolio
- 8.9.5 Cardia Recent Developments
- 8.10 MicroPort
- 8.10.1 MicroPort Company Information
- 8.10.2 MicroPort Business Overview
- 8.10.3 MicroPort Heart Defect Closure Devices Sales, Value and Gross Margin (2021-2026)
- 8.10.4 MicroPort Heart Defect Closure Devices Product Portfolio
- 8.10.5 MicroPort Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Heart Defect Closure Devices Value Chain Analysis
- 9.1.1 Heart Defect Closure Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Heart Defect Closure Devices Sales Mode & Process
- 9.2 Heart Defect Closure Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Heart Defect Closure Devices Distributors
- 9.2.3 Heart Defect Closure Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst